Aarth AIF Growth Fund decreased its stake in Accent Microcell from 1.29% to 1.15% by selling 34,000 shares for ₹1.78 crore at an approximate price of ₹524.45 per share.
A pharmaceutical manufacturer specializing in pharmaceutical excipients, Accent Microcell Ltd produces inactive substances used in drug formulation and delivery systems. Incorporated in 2012, the company serves pharmaceutical manufacturers across India and international markets. Its focused approach to excipient manufacturing positions it as a specialized ingredient supplier within the broader pharmaceutical manufacturing supply chain.
Jaipur-based fund managed by Adheesh Kabra and Rishi Agarwal. Runs a bottom-up, research-driven strategy targeting high-growth listed equities and SME-segment companies with strong cash flows and scalable models. Active anchor investor in SME IPOs. Holds 47 disclosed positions as of Q1 2026.